Free Trial

Veradigm (NASDAQ:MDRX) Shares Gap Down - Here's Why

Veradigm logo with Business Services background

Key Points

  • Veradigm Inc. (NASDAQ:MDRX) saw its shares gap down, opening at $4.95 after closing at $5.25, with a trading volume of 8,381 shares.
  • Wall Street Zen initiated coverage on Veradigm, assigning a "hold" rating and setting an average price target of $13.00 for the stock.
  • The company's 50-day moving average is currently $4.75, while its 200-day moving average is $4.59, indicating potential price volatility.
  • Five stocks we like better than Veradigm.

Veradigm Inc. (NASDAQ:MDRX - Get Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $5.25, but opened at $4.95. Veradigm shares last traded at $4.95, with a volume of 8,381 shares trading hands.

Analysts Set New Price Targets

Separately, Wall Street Zen began coverage on Veradigm in a report on Tuesday, May 20th. They set a "hold" rating for the company. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $13.00.

Check Out Our Latest Stock Analysis on MDRX

Veradigm Stock Performance

The firm's 50 day moving average price is $4.75 and its two-hundred day moving average price is $4.59.

About Veradigm

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Veradigm Right Now?

Before you consider Veradigm, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.

While Veradigm currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.